News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Winteam Sells Its 51% Ownership in Zhongtai Biological


8/28/2013 9:12:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 27, 2013 -- Winteam Pharma will sell its 51% stake in Guizhou Zhongtai Biological Technology for 101 million RMB ($16.5 million), representing a small gain of $2.5 million. Zhongtai is a plasma-based biopharma with operations in mainland China. In May, Winteam boughtTongjitang Chinese Medicines, paying $393 million, making it seem likely that Winteam is raising cash and focusing its operations. More details....

Stock Symbol: (HK: 00570)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES